Abstract
We examined the effects of intracerebroventricular (ICV) cannula implantation followed by the administration of morphine sulfate (MOR) and its metabolite, morphine-6-glucuronide (M6G), on the glycogen content of the brain, liver, and muscle. ICV cannulation resulted in nearly a 30% reduction in brain glycogen, and ICV MOR resulted in a 36% reduction in liver glycogen content compared to timematched controls, but it had no additional effect on either the brain or muscle glycogen content. ICV M6G showed a more significant reduction, to 50% of liver glycogen, but it had no effect on either brain or muscle glycogen. Neither IV MOR nor M6G produced any significant alteration in tissue glycogen content. These results indicate that the stress response associated with neurosurgery, especially the placement of the ICV cannula, is associated with a decrement in brain glycogen. The activation of opioid receptors in the brain results in enhanced hepatic glycogenolysis but has no additional effect on the brain glycogen content.
This is a preview of subscription content, log in via an institution to check access.
References
Lowry OH, Passonneau JV, Hasselberger FH, Schulz DW (1964) Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain. J Biol Chem 239:18–30
Eyre JA, Stuart AG, Forsyth RJ, Heaviside D, Bartlett K (1994) Glucose export from the brain in man: evidence for a role for astrocytic glycogen as a reservoir of glucose for neural metabolism. Brain Res 635:349–352
Swanson RA (1991) Physiologic coupling of glial glycogen metabolism to neuronal activity in brain. Can J Physiol Pharmacol 70:S138-S144
Masuo K, Yasui A, Nishida Y, Kumagai K, Sanada Y, Yoshitoshi A, Shinagawa Y (1993) The usefulness of postoperative continuous epidural morphine in abdominal surgery. Surg Today 23:95–99
Molina PE, Hashiguchi Y, Ajmal Y, Mazza M, Abumrad NN (1994) Differential hemodynamic, metabolic and hormonal effects of morphine and morphine-6-glucuronide. Brain Res 664:126–132
Hashiguchi Y, Molina PE, Abumrad NN (1995) Morphine-3-glucuronide: hyperglycemic and neuroendocrine potentiating effects. Brain Res 694:13–20
Roe JH, Dailey RE (1966) Determination of glycogen with the anthrone reagent. Anal Biochem 15:245–250
Paul D, Standifer KM, Inturrisi CE, Pternak W (1989) Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther 251:477–483
Mignat C, Wille U, Ziegler A (1995) Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes. Life Sci 56:793–799
Hand CW, Blunnie WP, Claffey LP, McShane AJ, McQay HJ, Moore RA (1987) Potential analgesic contribution from morphine-6-glucuronide in CSF. Lancet 2:1207–1208
Gunion MW, Rosenthal MJ, Morley JE, Miller S, Zib B, Butler B, Moore RD (1991) μ-receptor mediates elevated glucose and corticosterone after third ventricle injection of opioid peptides. Am J Physiol 261:R70-R81
Estler CJ (1966) Central nervous system activity, brain phosphorylase, and glycogen in acutely morphinized mice and rats. Int J Neuropharmacol 6:241–243
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hashiguchi, Y., Molina, P.E., Boxer, R. et al. Differential responses of brain, liver, and muscle glycogen to opiates and surgical stress. Surg Today 28, 471–474 (1998). https://doi.org/10.1007/s005950050168
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s005950050168